Aktienanalyse zu FMC Corp (FMC)FMCFMC Corp

FMC Corporation is a global agricultural sciences company engaged in providing farmers solutions that increase the productivity and resilience of their land. The Company’s crop protection solutions, including biologicals, crop nutrition, digital and precision agriculture, enable growers and crop advisers to address their challenges economically while protecting the environment. Its portfolio consists of three major pesticide categories: insecticides, herbicides and fungicides. The majority of its product lines consist of insecticides and herbicides, and it has a portfolio of fungicides mainly used in high-value crop segments. Its insecticides are used to control a wide spectrum of pests, while its herbicide portfolio primarily targets a large variety of difficult-to-control weeds. In addition, it is also investing in its Plant Health program, which includes biologicals, crop nutrition, and seed treatment products. Biological technologies serve as complements to its synthetic products. It operates in the Basic Materials sector (CHEMICALS & ALLIED PRODUCTS industry).

FMC Corp is not a good buy right now due to significant financial challenges and a drastically lowered revenue outlook. The current price is $5.66, which is down 32.22% over the last 5 days, and the company has cut its Q3 revenue forecast to between $65 million and $125 million, far below previous estimates of $840 million to $900 million. Additionally, the RSI is at a very low 6.87, indicating extreme oversold conditions, but this does not negate the severe risks associated with the stock. The main risk is the anticipated adjusted EBITDA loss of $510 million to $565 million, which highlights the company's ongoing struggles with demand and inventory management.

21 analysts cover FMC: 13 rate it Buy, 8 Hold and 0 Sell. The average price target is 19.08.